These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 25084775)
1. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775 [TBL] [Abstract][Full Text] [Related]
2. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473 [TBL] [Abstract][Full Text] [Related]
3. Incidence of pituitary adenomas in Northern Finland in 1992-2007. Raappana A; Koivukangas J; Ebeling T; Pirilä T J Clin Endocrinol Metab; 2010 Sep; 95(9):4268-75. PubMed ID: 20534753 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795 [TBL] [Abstract][Full Text] [Related]
5. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina. Day PF; Loto MG; Glerean M; Picasso MF; Lovazzano S; Giunta DH Arch Endocrinol Metab; 2016; 60(6):554-561. PubMed ID: 27982201 [TBL] [Abstract][Full Text] [Related]
6. [Pituitary adenomas--where is the treatment heading at the beginning of the 21st century?]. Marek J Vnitr Lek; 2010 Jul; 56(7):690-4. PubMed ID: 20842914 [TBL] [Abstract][Full Text] [Related]
7. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours. Norberg L; Johansson R; Rasmuson T Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004 [TBL] [Abstract][Full Text] [Related]
8. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood. Ragnarsson O; Höybye C; Jönsson PJ; Feldt-Rasmussen U; Johannsson G; Biller BM; Koltowska-Häggström M Eur J Endocrinol; 2012 Apr; 166(4):593-600. PubMed ID: 22258111 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of pituitary adenomas]. Mezosi E; Nemes O Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960 [TBL] [Abstract][Full Text] [Related]
11. Iran Pituitary Tumor Registry: Description of the Program and Initial Results. Khamseh ME; Mohajeri Tehrani MR; Mousavi Z; Malek M; Imani M; Hoshangian Tehrani N; Ghorbani M; Akbari H; Sarvghadi F; Amouzegar A; Esfahanian F; Hashemi Madani N; Emami Z Arch Iran Med; 2017 Dec; 20(12):746-751. PubMed ID: 29664314 [TBL] [Abstract][Full Text] [Related]
12. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR J Clin Endocrinol Metab; 2011 Apr; 96(4):964-71. PubMed ID: 21209028 [TBL] [Abstract][Full Text] [Related]
13. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Fernandez A; Karavitaki N; Wass JA Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784 [TBL] [Abstract][Full Text] [Related]
15. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas. Shao S; Li X J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272 [TBL] [Abstract][Full Text] [Related]
16. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. Ónnestam L; Berinder K; Burman P; Dahlqvist P; Engström BE; Wahlberg J; Nyström HF J Clin Endocrinol Metab; 2013 Feb; 98(2):626-35. PubMed ID: 23295463 [TBL] [Abstract][Full Text] [Related]
17. Age-related and gender-related occurrence of pituitary adenomas. Mindermann T; Wilson CB Clin Endocrinol (Oxf); 1994 Sep; 41(3):359-64. PubMed ID: 7893282 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study. Gruppetta M; Vassallo J Clin Endocrinol (Oxf); 2016 Aug; 85(2):223-31. PubMed ID: 26998693 [TBL] [Abstract][Full Text] [Related]
19. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Popovic V; Damjanovic S; Micic D; Nesovic M; Djurovic M; Petakov M; Obradovic S; Zoric S; Simic M; Penezic Z; Marinkovic J Clin Endocrinol (Oxf); 1998 Oct; 49(4):441-5. PubMed ID: 9876340 [TBL] [Abstract][Full Text] [Related]
20. The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas. Dogansen SC; Selcukbiricik OS; Bilir BE; Yarman S Growth Horm IGF Res; 2016 Aug; 29():45-49. PubMed ID: 27105040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]